Author

Y. H. Baek

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:benchmarking· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

J. H. Jeong· 3 shared M.-S. Song· 3 shared D. B. Lee· 2 shared E. J. Kim· 2 shared G. Lee· 2 shared H. Kim· 2 shared H. S. Jun· 2 shared J. Y. Maeng· 2 shared

Activity by Year

2022-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioengineering

J. H. Jeong

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mosaic display of stable hemagglutinin monomers induces broad immune responses

H. Kim, S. C. Min, D. B. Lee, J. H. Jeong, E. J. Kim, J. Y. Maeng, J. H. Seok, J.-H. Lee, Y. Jang, U. S. Jang, T. Ysenbaert, J. P. P. Catani, J. Lee, Y. Lee, Y. K. Kim, , K. H. Kim

This study develops a nanoparticle vaccine displaying conserved influenza HA epitopes, inducing broad neutralizing antibodies against multiple viral subtypes.

bioRxiv · Apr 10, 2024 · PreprintBioengineering

Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice

J. H. Jeong, S. Chokkakula, S. C. Min, B. Kim, W.-S. Choi, S. Oh, Y. S. Yun, D. H. Kang, O.-J. Lee, E.-G. Kim, J.-H. Choi, J.-Y. Lee, Y. K. Choi, Y. H. Baek, M.-S. Song

This paper evaluates combination antiviral therapies in SARS-CoV-2 infected mice, finding that nirmatrelvir and molnupiravir together significantly improve survival compared to monotherapies.

bioRxiv · Jun 27, 2022Microbiology

Mosaic receptor-binding domain nanoparticles induce protective immunity against SARS-CoV-2 challenges

D. B. Lee, H. Kim, J. H. Jeong, E. s. Jang, Y. Y. Chang, S. Roh, H. Jeon, E. J. Kim, S. Y. Han, J. Y. Maeng, S. Magez, M. Radwanska, J. Y. Mun, H. S. Jun, G. Lee, , K. H. Kim

This paper develops a mosaic nanoparticle vaccine, 6RBD-np, that induces full protection against SARS-CoV-2 wild type and Delta variants in mice.

bioRxiv · Feb 18, 2022 · PreprintBioengineering